Singapore markets closed

Biocartis Group NV (8XB.BE)

Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
0.28950.0000 (0.00%)
At close: 07:22AM CET
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
60,612
57,481
48,269
43,128
Cost of revenue
29,457
29,799
33,922
26,284
Gross profit
31,155
27,682
14,347
16,844
Operating expenses
Research development
37,506
38,393
48,054
40,927
Selling general and administrative
8,922
8,573
6,403
6,541
Total operating expenses
73,921
74,433
76,645
63,226
Operating income or loss
-42,766
-46,751
-62,298
-46,382
Interest expense
16,091
11,187
9,320
10,184
Income before tax
-68,035
-65,621
-71,715
-63,162
Income tax expense
-167
-240
-243
-228
Income from continuing operations
-67,868
-65,381
-71,472
-62,934
Net income
-67,868
-65,381
-71,472
-62,934
Net income available to common shareholders
-67,868
-65,381
-71,472
-62,934
Basic EPS
-0.92
-1.08
-1.24
-0.95
Diluted EPS
-0.92
-1.08
-1.24
-0.95
Basic average shares
78,389
60,546
57,546
66,381
Diluted average shares
78,389
60,546
57,546
66,381